Breast Cancer
Research
A Phase II Tolerability Trial of Neoadjuvant Docetaxel with Carboplatin and Capecitabine in Locally Advanced Breast Cancer
News
Low Vitamin D Associated With Poor Prognostic Features in Breast Cancer
Finding: Vitamin D deficiency was more than twice as common as normal levels in women undergoing surgery for breast cancer (OR, 2.4).Data Source:...
News
CDER: Avastin Breast Cancer Claim Undermines Approval Process
News
Genentech Appeals to FDAs Regulatory Flexibility on Avastin
News
Radioactive Seeds Guide Surgeons to Nonpalpable Breast Lesions
Major Finding: Radioactive seed localization resulted in initial negative margins in 85% of cases and an overall re-excision rate of 2%. Data...
News
Sequencing Reveals MAP3K1 Mutation in Luminal-Type Breast Cancer
Major Finding: A three-gene cluster of mutated MAP3K1, mutated PIK3CA, and wild-type TP53 was shown to be significantly associated with "luminal A...
News
NCCN Breast Guidelines Stand by Bevacizumab
News
Bone Micrometastases Show No Survival Impact in Early Breast Cancer
Major Finding: Overall survival was 92.7% in patients without BMM and 92.5% in those with BMM.Data Source: A prospective Swiss Multicenter Study...
News
Clinical Trial Participation Tied to Improved Breast Cancer Outcomes
Major Finding: Among 1,220 women, 56% of patients treated by a surgical oncologist participated in a clinical trial, compared with 7% of general...
News
Techniques Compared for Breast Tumor Detection
Major Finding: Positive margin rates were 10.5% for radio-guided seed localization and 11.9% for wire-guided localization.Data Source: Prospective...
News
Eribulin Extends Survival of Women With Heavily Pretreated Breast Cancer
Major Finding: Median overall survival rate reached 13.1 months in women treated with eribulin, compared with 10.6 months in the control group (P...